Sei Investments Co. Has $165.19 Million Stake in Cencora, Inc. $COR

Sei Investments Co. increased its holdings in shares of Cencora, Inc. (NYSE:COR) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 528,528 shares of the company’s stock after buying an additional 6,706 shares during the period. Sei Investments Co. owned 0.27% of Cencora worth $165,190,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. IAG Wealth Partners LLC bought a new position in Cencora in the third quarter valued at approximately $30,000. Vermillion & White Wealth Management Group LLC raised its position in shares of Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after acquiring an additional 43 shares during the last quarter. Cloud Capital Management LLC bought a new stake in shares of Cencora during the 3rd quarter valued at $31,000. Caitlin John LLC acquired a new position in shares of Cencora in the 3rd quarter valued at $31,000. Finally, Westside Investment Management Inc. lifted its stake in shares of Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after purchasing an additional 70 shares during the period. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Cencora news, EVP Elizabeth S. Campbell sold 3,351 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the sale, the executive vice president directly owned 23,891 shares in the company, valued at approximately $8,173,111.10. This trade represents a 12.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,220 shares of company stock worth $5,282,867 in the last 90 days. Corporate insiders own 0.38% of the company’s stock.

Cencora Price Performance

COR opened at $352.39 on Friday. The stock has a market cap of $68.55 billion, a P/E ratio of 42.35, a P/E/G ratio of 1.63 and a beta of 0.68. Cencora, Inc. has a 12 month low of $252.49 and a 12 month high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The company has a fifty day simple moving average of $355.37 and a 200 day simple moving average of $337.70.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. During the same period in the previous year, the company posted $3.73 earnings per share. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, research analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s payout ratio is 28.85%.

Analysts Set New Price Targets

COR has been the subject of a number of analyst reports. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. increased their target price on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Robert W. Baird set a $415.00 target price on Cencora in a report on Tuesday, January 13th. Evercore decreased their target price on Cencora from $440.00 to $420.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. Finally, Barclays upped their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Eleven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and a consensus target price of $399.00.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.